Teleflex Introduces New ARROW® SureBlock® Spinal Anesthesia Collection
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE:TFX) today announced the launch of its new ARROW SureBlock Spinal Anesthesia Collection. This follows closely after the recent launch of the Companys new ARROW FlexTip Plus® Multi-Port epidural catheter.
The SureBlock Collection includes spinal anesthesia full medication kits, safety kits, and intermediate and basic sets, all featuring the Sprotte® spinal needle, which has been clinically proven to minimize the incidence of postdural puncture headaches.(1,2) The SureBlock Collection also includes individually packaged sterile Sprotte needles in a wide range of gauges and lengths to provide more flexibility for the anesthesia provider.
Teleflex (TFX) released a limited spinal anesthesia offering under the ARROW SureBlock brand in 2009 now this offering has been enhanced and expanded based on extensive feedback from clinicians. The SureBlock Collection of kits and sets will now include a glass barrel syringe to further aid in the fast, positive identification of the spinal space. These kits and sets also are now available with more drug combinations to complete the spinal anesthesia portfolio.
We expanded and redesigned the SureBlock product offering to provide more ARROW brand solutions for anesthesiologists to meet their changing needs, said Cary Vance, President, Teleflex Anesthesia and Respiratory. By providing more products for more procedures, designed around patient safety and greater ease of use and reliability for the anesthesia provider, we strive to simplify the customers supply chain. SureBlock is just one in a series of new products enabling Teleflex to help provide this solution.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,200 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Arrow, FlexTip Plus, SureBlock, and Teleflex are registered
trademarks of Teleflex Incorporated or its affiliates. Sprotte is a
registered trademark of Pajunk GmbH.
©2012 Teleflex Incorporated. Lit. No. 2012-1283.
1. Toyka KV, Müller B, Reichmann H, Strupp M, Schüler O, Brandt T.
"Atraumatic" Sprotte needle reduces the incidence of post-lumbar
puncture headaches. Neurology 2002; 59: 1120-21.
2. Pittoni G, Toffoletto F, Calcarella G, Zanette G, Giron GP. Spinal anesthesia in outpatient knee surgery: 22-gauge versus 25-gauge Sprotte needle. Anesth Analg. 1995; 81: 73-9.
Treasurer and Vice President, Investor Relations
Source: Teleflex IncorporatedCopyright Business Wire 2012